Director, Process Development
Kyverna TherapeuticsHighlight
Summary
About the Role
About You
- Advanced degree in Cell Biology, Immunology, Molecular Biology, Chemical Engineering, Biotechnology, or a related field; PhD preferred.
- 10+ years of experience in pharmaceutical manufacturing, technology transfer, and process development.
- Proven expertise in CAR-T or other ex vivo gene-modified cell therapy process development.
- Experience advancing product development on closed automated platforms.
- Strong expertise in cGMP manufacturing and associated pharmaceutical regulatory requirements.
- Demonstrated success leading high-performing development teams.
Benefits
- Competitive salary range of $210k–$235k.
- Eligibility for bonus, benefits, and participation in the Company’s stock plan.
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna’s pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.